Mrs. Golnaz Atri Roozbahani | Prostate Cancer Research | Best Researcher Award

Publications

H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells

  • Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Cancers
  • Year: 2025

The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and-agonist to stimulate growth of target cells

  • Authors: Golnaz Atri Roozbahani, Miriam Kokal-Ribaudo, Mehdi Heidari Horestani, Thanakorn Pungsrinont, Aria Baniahmad
  • Journal: Cell Communication and Signaling
  • Year: 2024

The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer

  • Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Journal of Experimental & Clinical Cancer Research
  • Year: 2024

The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer

  • Authors: Julia Kallenbach, Mahdi Rasa, Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Katrin Schindler, Aria Baniahmad
  • Journal: Journal of Experimental & Clinical Cancer Research
  • Year: 2024

The Novel Direct AR Target Gene Annexin A2 Mediates Androgen-Induced Cellular Senescence in Prostate Cancer Cells

  • Authors: Kimia Mirzakhani, Mehdi Heidari Horestani, Julia Kallenbach, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Biochemical Genetics
  • Year: 2024

Mr. Mehdi Heidari Horestani | Cancer Genetics | Best Researcher Award

Publications

H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells

  • Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Cancers
  • Year: 2025

The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and-agonist to stimulate growth of target cells

  • Authors: Golnaz Atri Roozbahani, Miriam Kokal-Ribaudo, Mehdi Heidari Horestani, Thanakorn Pungsrinont, Aria Baniahmad
  • Journal: Cell Communication and Signaling
  • Year: 2024

The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer

  • Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Journal of Experimental & Clinical Cancer Research
  • Year: 2024

The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer

  • Authors: Julia Kallenbach, Mahdi Rasa, Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Katrin Schindler, Aria Baniahmad
  • Journal: Journal of Experimental & Clinical Cancer Research
  • Year: 2024

Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence

  • Authors: Mehdi Heidari Horestani, Katrin Schindler, Aria Baniahmad
  • Journal: Cell Communication and Signaling
  • Year: 2024

Mr. Miguel Garcia-de la Virgen | Oncology | Best Researcher Award

Mr. Miguel Garcia-de la Virgen | Oncology | Best Researcher Award

Miguel Garcia-de la Virgen at IVC Evidensia – AĆŗna Especialidades Veterinariass, Spain

Profiles

Orcid

Summary

Mr. Miguel Garcia de la Virgen is a skilled veterinary oncologist with extensive experience in cancer treatment for animals. A resident of the European College of Veterinary Internal Medicine (ECVIM-CA), he is committed to advancing veterinary oncology through research and clinical practice.

Education

  • General Practitioner Certificate in Oncology (2014-2015) ā€“ European School of Veterinary Postgraduate Studies (ESVPS), Madrid
  • Masterā€™s in Clinical Oncology (2013-2014) ā€“ AsociaciĆ³n EspaƱola de Veterinaria Aplicada (AEVA), Madrid
  • Veterinary Degree (2007-2012) ā€“ University of Zaragoza, Spain.

šŸ’¼Ā Professional Experience

  • Oncology Resident (2018-2020) ā€“ Hospital Veterinario AĆŗna Especialidades Veterinarias, Paterna, Valencia
  • Oncology Team Member (2016-2018) ā€“ Hospital Veterinari Montjuic, Barcelona
  • General Internship (2015-2016) ā€“ Hospital ClĆ­nic Veterinari, Universitat AutĆ²noma de Barcelona
  • First Opinion Veterinary Clinician (2012-2015) ā€“ ClĆ­nica Veterinaria OrdĆ”s, AlgemesĆ­, ValĆØncia

šŸ”¬ Research Interests

  • Miguel focuses on innovative cancer treatments, clinical trials, and improving oncological care in veterinary medicine.

 

Publications

Impact of Toceranib Phosphate and Carprofen on Survival and Quality of Life in Dogs with Inflammatory Mammary Carcinomas

  • Authors: Miguel Garcia-de la Virgen, Isabel Del Portillo Miguel, Elisa Maiques, Ignacio PĆ©rez Roger, Enric Poch, Juan Borrego
  • Journal: Veterinary Sciences
  • Year: 2024

Clinical and genomic features of Listeria monocytogenesā€associated mesenteric lymphadenitis in a cat

  • Authors: Miguel Garcia-de la Virgen, Inmaculada LĆ³pezā€Almela, Alexandra Moura, Sergio VĆ”zquez, Sara Perezā€Montagud, Alexandre Leclercq, Marc Lecuit, Juan J Quereda
  • Journal: Journal of Veterinary Internal Medicine
  • Year: 2024

Prof. Bin Zhang | Tumorigenesis | Best Researcher Award

Prof. Bin Zhang, Tumorigenesis, Best Researcher Award

Bin Zhang at Jining Medical University, China

Professional Profile

šŸŒŸĀ Summary:

Prof. Bin Zhang is a distinguished Taishan Mount Scholar in China, recognized for his expertise in tumor metabolism research. He leads a dynamic research group focusing on tumor stem cells, tumor biomacromolecules, oncogenic gene mutations, and drug screening for tumor metabolism targets. His impactful contributions have significantly advanced understanding in oncology.

šŸ’¼ Professional Experience:

Since 2018, Prof. Zhang has served as a researcher at the Affiliated Hospital of Jining Medical University. He established and leads the tumor metabolism research group, playing a pivotal role as the Principal Investigator.

šŸ”¬ Research Interests:

  • Regulatory mechanisms of tumor stem cells
  • Specificity of tumor biomacromolecules and energy metabolism
  • Regulation of energy metabolism by oncogenic gene mutations
  • Potential drug screening for tumor metabolism targets

šŸ“– Publications Top Noted:

Paper Title: Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines
  • Authors: Zhang, B.; Sim, W.K.; Shen, T.-L.; Lim, S.K.
  • Journal: Journal of Biomedical Science
  • Volume: 31
  • Issue: 1
  • Pages: 9
  • Year: 2024
  • Citations: 1
Paper Title: Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling
  • Authors: He, B.; Bie, Q.; Zhao, R.; Xiong, H.; Zhang, B.
  • Journal: Cell Reports Medicine
  • Volume: 5
  • Issue: 5
  • Pages: 101510
  • Year: 2024
Paper Title: Exosomes from umbilical cord mesenchymal stem cells ameliorate intervertebral disc degeneration via repairing mitochondrial dysfunction
  • Authors: Jia, S.; Yang, T.; Gao, S.; Zhang, B.; Meng, C.
  • Journal: Journal of Orthopaedic Translation
  • Volume: 46
  • Pages: 103ā€“115
  • Year: 2024
  • Citations: 1
Paper Title: Standard Radio-Iodine Labeling Protocols Impaired the Functional Integrity of Mesenchymal Stem/Stromal Cell Exosomes
  • Authors: Yang, C.-T.; Lai, R.C.; Phua, V.J.X.; Lim, S.K.; Ng, D.C.E.
  • Journal: International Journal of Molecular Sciences
  • Volume: 25
  • Issue: 7
  • Pages: 3742
  • Year: 2024
Paper Title: IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53
  • Authors: He, B.; Liang, J.; Qin, Q.; Zhang, B.; Zhang, B.
  • Journal: Genes and Diseases
  • Volume: 11
  • Issue: 1
  • Pages: 495ā€“508
  • Year: 2024
  • Citations: 5